High frequency of Chlamydia pneumoniae and risk factors in children with acute respiratory infection.

Matheus Silva Alves, Marilha da Silva Cariolano, Hivylla Lorrana Dos Santos Ferreira, Elen Sousa de Abreu Silva, Karen Karollynny Pereira Felipe, Silvio Gomes Monteiro, Eduardo Martins de Sousa, Afonso Gomes Abreu, Lee Ann Campbell, Michael E Rosenfeld, Mario Hiroyuki Hirata, Rosario Dominguez Crespo Hirata, Gisele Medeiros Bastos, Ilana Cristina de Paula Abreu Silva, Lidio Gonçalves Lima-Neto
Author Information
  1. Matheus Silva Alves: Programa de Pós-Graduação, Universidade CEUMA, Rua dos Castanheiros, no. 1, Renascença II, Sao Luis, MA, 65075-120, Brazil.
  2. Marilha da Silva Cariolano: Programa de Pós-Graduação, Universidade CEUMA, Rua dos Castanheiros, no. 1, Renascença II, Sao Luis, MA, 65075-120, Brazil.
  3. Hivylla Lorrana Dos Santos Ferreira: Programa de Pós-Graduação, Universidade CEUMA, Rua dos Castanheiros, no. 1, Renascença II, Sao Luis, MA, 65075-120, Brazil.
  4. Elen Sousa de Abreu Silva: Programa de Pós-Graduação, Universidade CEUMA, Rua dos Castanheiros, no. 1, Renascença II, Sao Luis, MA, 65075-120, Brazil.
  5. Karen Karollynny Pereira Felipe: Programa de Pós-Graduação, Universidade CEUMA, Rua dos Castanheiros, no. 1, Renascença II, Sao Luis, MA, 65075-120, Brazil.
  6. Silvio Gomes Monteiro: Programa de Pós-Graduação, Universidade CEUMA, Rua dos Castanheiros, no. 1, Renascença II, Sao Luis, MA, 65075-120, Brazil.
  7. Eduardo Martins de Sousa: Programa de Pós-Graduação, Universidade CEUMA, Rua dos Castanheiros, no. 1, Renascença II, Sao Luis, MA, 65075-120, Brazil.
  8. Afonso Gomes Abreu: Programa de Pós-Graduação, Universidade CEUMA, Rua dos Castanheiros, no. 1, Renascença II, Sao Luis, MA, 65075-120, Brazil.
  9. Lee Ann Campbell: Department of Global Health, University of Washington, Seattle, WA, USA.
  10. Michael E Rosenfeld: Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA.
  11. Mario Hiroyuki Hirata: Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
  12. Rosario Dominguez Crespo Hirata: Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
  13. Gisele Medeiros Bastos: Institute Dante Pazzanese of Cardiology, Sao Paulo, SP, Brazil.
  14. Ilana Cristina de Paula Abreu Silva: Curso de Medicina, Universidade CEUMA, Sao Luis, MA, Brazil.
  15. Lidio Gonçalves Lima-Neto: Programa de Pós-Graduação, Universidade CEUMA, Rua dos Castanheiros, no. 1, Renascença II, Sao Luis, MA, 65075-120, Brazil. lidio.neto@outlook.com. ORCID

Abstract

This study was performed as a contribution for a better understanding of Chlamydia pneumoniae frequency in children with respiratory infections. A total of 416 children were recruited from two clinical centers in Sao Luis, Brazil. Of these patients, 165 children had upper respiratory tract infections (URTI), 150 had community-acquired pneumonia (CAP), and 101 were asymptomatic volunteer children. Clinical and epidemiological data from the participants were recorded. Nasopharyngeal swab samples were collected to extract DNA. C. pneumoniae DNA positivity and copy numbers were obtained by an absolute quantitative real-time PCR method. RESULTS: Positivity for C. pneumoniae DNA was higher in samples from URTI children (38.2%) and from CAP children (18.0%) than in those from the control group (7.9%; p < 0.001). Moreover, C. pneumoniae DNA was denser in children with URTI than in asymptomatic children. Considering the cutoff, the highest value of C. pneumoniae DNA found in asymptomatic children of the 3.98 log10 copies/mL, 8.5% (14/165) of the children with URTI, and 3.3% (5/150) with CAP presented high copy numbers of C. pneumoniae DNA. CONCLUSION: Taken together, these results revealed a high frequency of C. pneumoniae in both children with URTI and CAP.

Keywords

References

  1. PLoS One. 2015 Mar 09;10(3):e0119170 [PMID: 25751402]
  2. J Infect Dis. 1993 Nov;168(5):1231-5 [PMID: 8228356]
  3. PLoS One. 2017 Jan 27;12(1):e0170787 [PMID: 28129377]
  4. Microbes Infect. 2010 Aug;12(8-9):598-606 [PMID: 20417302]
  5. J Infect Dis. 1998 May;177(5):1322-5 [PMID: 9593019]
  6. Int J Infect Dis. 2015 Sep;38:101-7 [PMID: 26255889]
  7. PLoS One. 2014 May 05;9(5):e96674 [PMID: 24797911]
  8. Clin Infect Dis. 1995 May;20(5):1174-8 [PMID: 7619996]
  9. J Biol Regul Homeost Agents. 2014 Jul-Sep;28(3):449-60 [PMID: 25316132]
  10. Anal Bioanal Chem. 2011 Aug;401(2):717-26 [PMID: 21603916]
  11. J Bras Pneumol. 2018 Sep-Oct;44(5):405-423 [PMID: 30517341]
  12. Int J Mol Sci. 2016 Dec 16;17(12): [PMID: 27999274]
  13. Lancet. 2013 Apr 20;381(9875):1405-1416 [PMID: 23582727]
  14. FEMS Microbiol Lett. 2015 Mar;362(6): [PMID: 25663156]
  15. J Periodontol. 2012 Jun;83(6):744-52 [PMID: 22060046]
  16. Clin Infect Dis. 2017 Aug 15;65(4):604-612 [PMID: 28605562]
  17. Clin Microbiol Infect. 2008 Apr;14(4):322-9 [PMID: 18190569]
  18. J Clin Microbiol. 2002 Jun;40(6):2273-4 [PMID: 12037108]
  19. Clin Infect Dis. 2001 Aug 15;33(4):492-503 [PMID: 11462186]
  20. PLoS One. 2013 Dec 31;8(12):e83600 [PMID: 24391792]
  21. Circulation. 2001 Jan 23;103(3):351-6 [PMID: 11157684]
  22. Bull World Health Organ. 2005 May;83(5):353-9 [PMID: 15976876]
  23. Front Cell Infect Microbiol. 2014 Mar 21;4:34 [PMID: 24711989]
  24. Antimicrob Agents Chemother. 1996 Nov;40(11):2669-70 [PMID: 8913488]
  25. N Engl J Med. 1986 Jul 17;315(3):161-8 [PMID: 3724806]
  26. Int J Antimicrob Agents. 2017 Aug;50(2):247-251 [PMID: 28599867]
  27. Lancet. 2006 Sep 23;368(9541):1048-50 [PMID: 16997649]
  28. J Clin Virol. 2015 Aug;69:190-6 [PMID: 26209405]
  29. J Clin Microbiol. 1991 Sep;29(9):2082-3 [PMID: 1774340]
  30. J Med Microbiol. 2002 Aug;51(8):623-625 [PMID: 12171291]
  31. Eur J Pediatr. 2013 Apr;172(4):493-9 [PMID: 23271491]
  32. Arch Dis Child. 2015 Feb;100 Suppl 1:S23-8 [PMID: 25613963]
  33. Chest. 2001 May;119(5):1416-9 [PMID: 11348947]

Grants

  1. #PPSUS-03384/13/Ministério da Saúde

MeSH Term

Acute Disease
Brazil
Child
Child, Preschool
Chlamydophila Infections
Chlamydophila pneumoniae
Community-Acquired Infections
DNA, Bacterial
Humans
Infant
Nasopharynx
Pneumonia, Bacterial
Respiratory Tract Infections
Risk Factors

Chemicals

DNA, Bacterial

Word Cloud

Created with Highcharts 10.0.0childrenpneumoniaeDNACURTIrespiratoryCAPChlamydiafrequencyasymptomaticinfectionssamplescopynumbers3highinfectionstudyperformedcontributionbetterunderstandingtotal416recruitedtwoclinicalcentersSaoLuisBrazilpatients165uppertract150community-acquiredpneumonia101volunteerClinicalepidemiologicaldataparticipantsrecordedNasopharyngealswabcollectedextractpositivityobtainedabsolutequantitativereal-timePCRmethodRESULTS:Positivityhigher382%180%controlgroup79%p < 0001MoreoverdenserConsideringcutoffhighestvaluefound98log10copies/mL85%14/1653%5/150presentedCONCLUSION:TakentogetherresultsrevealedHighriskfactorsacuteAcuteChildren

Similar Articles

Cited By